Group One Trading’s Eton Pharmaceutcials ETON Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-500
Closed -$8.74K 7930
2025
Q4
$8.46K Sell
500
-262
-34% -$4.61K ﹤0.01% 6905
2025
Q3
$16.6K Buy
+762
New +$12.6K ﹤0.01% 6841
2025
Q2
Sell
-634
Closed -$10K 8095
2025
Q1
$8.23K Buy
+634
New +$9.58K ﹤0.01% 6386
2024
Q4
Sell
-722
Closed -$7.32K 7451
2024
Q3
$4.33K Buy
+722
New +$3.05K ﹤0.01% 5934
2022
Q4
Sell
-608
Closed -$1.64K 7460
2022
Q3
$1K Sell
608
-7,201
-92% -$17.9K ﹤0.01% 7297
2022
Q2
$20K Sell
7,809
-18,510
-70% -$62.1K ﹤0.01% 6280
2022
Q1
$115K Sell
26,319
-12,481
-32% -$49.1K ﹤0.01% 5359
2021
Q4
$166K Buy
38,800
+24,756
+176% +$118K ﹤0.01% 5260
2021
Q3
$71K Buy
+14,044
New +$73.1K ﹤0.01% 6242

Other funds holding ETON

Group One Trading's ETON Position: Q1 2026 in Review

Group One Trading sold out of Eton Pharmaceutcials (ETON) in Q1 2026, closing a stake of 500 shares — an estimated $8.74K sold.

Group One Trading first reported a position in ETON in Q3 2021 and held it in 9 quarters. The position peaked at $166K in Q4 2021. 116 funds tracked by Wall St. Rank hold ETON as of Q1 2026.

  • Group One Trading reported no remaining Eton Pharmaceutcials position as of Q1 2026 after selling out during the quarter.
  • Group One Trading sold 500 Eton Pharmaceutcials shares in Q1 2026, an estimated $8.74K.
  • Group One Trading first reported a position in Eton Pharmaceutcials in Q3 2021 and held it in 9 quarters.
  • Group One Trading's Eton Pharmaceutcials position peaked at $166K in Q4 2021.
  • 116 funds tracked by Wall St. Rank held Eton Pharmaceutcials as of Q1 2026.

Based on Group One Trading's 13F filing for Q1 2026, filed 13 May 2026.